Identification novel angiotensin I-converting enzyme (ACE) inhibitory peptides from wheat gluten hydrolysate by the protease of Pseudomonas aeruginosa

Peng Zhang, Chang Chang, Haijie Liu, Bo Li, Qiaojuan Y, Zhengqiang Jiang, Identification of novel angiotensin I-converting enzyme (ACE) inhibitory peptides from wheat gluten hydrolysate by the protease of Pseudomonas aeruginosaJournal of Functional Foods (2020) doi.org/10.1016/j.jff.2019.103751

The feasibility of a protease of Pseudomonas aeruginosa (PaproA) to prepare angiotensin I-converting enzyme (ACE) inhibitory peptides from wheat gluten was evaluated according to physiochemical and antihypertensive performances. The wheat gluten hydrolyzed by Alcalase plus PaproA (WGH_APae) to produce small fragments (<1 kDa) was particularly preferred by the superior protein recovery rate, degree of hydrolysis, ACE inhibitory potential, and stability against gastrointestinal digestion. Among the resultant fractions from WGH_APae, the lower IC50 value of fraction 7 indicated proper concentrations of proline and negatively charged amino acids were critical to modulate ionic and hydrophobic interactions on ACE catalytic sites to inhibit ACE activity. Subsequently, fraction 7 was purified to identify two successful antihypertensive peptides containing tryptophan at the carboxyl-end: SAGGYIW and APATPSFW with IC50 values of 0.002 mg/mL and 0.036 mg/mL, respectively, suggesting both peptides had potentials in the nutraceuticals and functional foods to prevent and/or treat hypertension.